Anne Tierens

TL;DR: C‐erbB‐2 expression in breast carcinomas is associated with an unfavourable clinical course and EGFR expression has a synergistic effect, however, c‐erb B‐4 antagonizes the c‐ DerbyshireB‐4 effect on clinical course in Breast carcinomas.

TL;DR: Investigating whether lymphoma patients undergoing rituximab-containing treatment regimens or having received such regimens within the past 6 months were able to mount protective antibody responses to the influenza A(H1N1) 2009 virus vaccine Pandemrix during the 2009 "swine flu" pandemic found none of the 67 patients achieved protective antibody titers.

TL;DR: It is shown that marginal-zone B cells may cycle and that clones of B cells are frequently detected in the nodal as well as the splenic marginal zone, which favor the hypothesis that clonal expansion occurs in the marginal zone.

TL;DR: The study confirmed that B-cell-specific activator protein but not Oct-2 is not expressed by cHD, and likely contributes to the lack of immunoglobulin expression and incomplete B- cell phenotype characteristic of the Reed-Sternberg cells in cHD.

TL;DR: The absence of plasmacytoid cells, the presence of plasma cells predominantly outside the nodular lymphoid infiltrates, IGHV4-34 restriction and absence of MYD88 L265P mutation strongly suggest that cold agglutinin-associated lymphoproliferative disease is a distinct entity that is different from lymphoplasmacytic lymphoma.